AI filing briefs · archive

8-K filings in March 2025, explained

442 material Form 8-K filings that 386 companies we cover made with the SEC in March 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

2 of 442 briefs match

newest first · times in ET
CXWCoreCivic, Inc. Mar 7, 5:21 PM ET

CoreCivic agrees to resume ICE operations at Dilley, Texas facility

Positive product/contract Written later 5.028.01

CoreCivic agreed under an amended intergovernmental services agreement with the City of Dilley, Texas and ICE to resume operations and care for up to 2,400 individuals at the South Texas Family Residential Center, and entered a new lease with Target Hospitality Corporation, the facility owner, over a period matching the ICE agreement. The company expects total annual revenue of about $180 million once the facility is fully activated and expects the award to be accretive to earnings beginning in the second quarter of 2025. The filing also adds three independent directors effective March 17, 2025, and reports that director Robert Dennis will not stand for re-election at the 2025 Annual Meeting.

  • Up to 2,400 individuals at the Dilley facility; amended IGSA expires in March 2030 and may be extended
  • Expected total annual revenue of about $180 million once fully activated, inclusive of medical services
  • S. Dawn Smith, Stacey Tank and Nina Tran join the Board effective March 17, 2025; Robert Dennis will leave at the 2025 Annual Meeting, reducing the Board to twelve
Read the filing on SEC.gov ↗
DXPEDXP ENTERPRISES INC Mar 7, 5:13 PM ET

DXP Enterprises Q4 sales rise to $470.9 million; full-year diluted EPS $4.22

Positive earnings Written later 2.02

DXP Enterprises reported fourth-quarter and fiscal 2024 results in a press release furnished under Item 2.02. Fourth-quarter sales rose to $470.9 million from $407.0 million, and diluted EPS rose to $1.29 from $0.94. For the full year, sales grew 7.4 percent to $1.8 billion and net income reached $70.5 million, up from $68.8 million, so shareholders saw higher sales and profit on both measures.

  • Q4 2024 sales were $470.9 million versus $407.0 million in Q4 2023; diluted EPS was $1.29 versus $0.94.
  • Fiscal 2024 diluted EPS was $4.22 versus $3.89 in fiscal 2023; net income was $70.5 million versus $68.8 million.
  • Fiscal 2024 free cash flow was $77.1 million, down from $94.0 million in fiscal 2023.
  • The company refinanced its Senior Secured Term Loan B, raising $649.5 million, and repurchased 0.6 million shares for $28.8 million in fiscal 2024.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.